Paclitaxel and curcumin coadministration in novel cationic PEGylated niosomal formulations exhibit enhanced synergistic antitumor efficacy
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1477-3155
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Paclitaxel and curcumin coadministration in novel cationic PEGylated niosomal formulations exhibit enhanced synergistic antitumor efficacy ; volume:16 ; number:1 ; day:23 ; month:3 ; year:2018 ; pages:1-20 ; date:12.2018
Journal of nanobiotechnology ; 16, Heft 1 (23.3.2018), 1-20, 12.2018
- Creator
-
Alemi, Ashraf
- Contributor
-
Zavar Reza, Javad
Haghiralsadat, Fateme
Zarei Jaliani, Hossein
Haghi Karamallah, Mojtaba
Hosseini, Seyed Ahmad
Haghi Karamallah, Somayeh
SpringerLink (Online service)
- DOI
-
10.1186/s12951-018-0351-4
- URN
-
urn:nbn:de:1111-201805278164
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:38 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Alemi, Ashraf
- Zavar Reza, Javad
- Haghiralsadat, Fateme
- Zarei Jaliani, Hossein
- Haghi Karamallah, Mojtaba
- Hosseini, Seyed Ahmad
- Haghi Karamallah, Somayeh
- SpringerLink (Online service)
Other Objects (12)
Synergistic co-administration of docetaxel and curcumin to chemoresistant cancer cells using PEGylated and RIPL peptide-conjugated nanostructured lipid carriers
Cationic PEGylated polycaprolactone nanoparticles carrying post-operation docetaxel for glioma treatment
Passively Targeted Curcumin‐Loaded PEGylated PLGA Nanocapsules for Colon Cancer Therapy In Vivo
PEGylated versus non-PEGylated magnetic nanoparticles as camptothecin delivery system
Promising PEGylated cationic dendrimers for delivery of miRNAs as a possible therapy against HIV-1 infection
PEGylated recombinant human hyaluronidase (PEGPH20) pre-treatment improves intra-tumour distribution and efficacy of paclitaxel in preclinical models
Elevated alpha1-acid glycoprotein in gastric cancer patients inhibits the anticancer effects of paclitaxel, effects restored by co-administration of erythromycin
Observation of antitumor mechanism of GE11-modified paclitaxel and curcumin liposomes based on cellular morphology changes
Safety evaluation of PEGylated MNPs and p-PEGylated MNPs in SD rats
Efficient Delivery of Gold Nanoparticles and miRNA-33a Via Cationic PEGylated Niosomal Formulation to MCF-7 Breast Cancer Cells
Co-delivery of paclitaxel and curcumin to foliate positive cancer cells using Pluronic-coated iron oxide nanoparticles
Phase 2 study of canfosfamide in combination with pegylated liposomal doxorubicin in platinum and paclitaxel refractory or resistant epithelial ovarian cancer
Synergistic co-administration of docetaxel and curcumin to chemoresistant cancer cells using PEGylated and RIPL peptide-conjugated nanostructured lipid carriers
Cationic PEGylated polycaprolactone nanoparticles carrying post-operation docetaxel for glioma treatment
Passively Targeted Curcumin‐Loaded PEGylated PLGA Nanocapsules for Colon Cancer Therapy In Vivo
PEGylated versus non-PEGylated magnetic nanoparticles as camptothecin delivery system
Promising PEGylated cationic dendrimers for delivery of miRNAs as a possible therapy against HIV-1 infection
PEGylated recombinant human hyaluronidase (PEGPH20) pre-treatment improves intra-tumour distribution and efficacy of paclitaxel in preclinical models
Elevated alpha1-acid glycoprotein in gastric cancer patients inhibits the anticancer effects of paclitaxel, effects restored by co-administration of erythromycin
Observation of antitumor mechanism of GE11-modified paclitaxel and curcumin liposomes based on cellular morphology changes
Safety evaluation of PEGylated MNPs and p-PEGylated MNPs in SD rats
Efficient Delivery of Gold Nanoparticles and miRNA-33a Via Cationic PEGylated Niosomal Formulation to MCF-7 Breast Cancer Cells
Co-delivery of paclitaxel and curcumin to foliate positive cancer cells using Pluronic-coated iron oxide nanoparticles
Phase 2 study of canfosfamide in combination with pegylated liposomal doxorubicin in platinum and paclitaxel refractory or resistant epithelial ovarian cancer
Synergistic co-administration of docetaxel and curcumin to chemoresistant cancer cells using PEGylated and RIPL peptide-conjugated nanostructured lipid carriers
Cationic PEGylated polycaprolactone nanoparticles carrying post-operation docetaxel for glioma treatment
Passively Targeted Curcumin‐Loaded PEGylated PLGA Nanocapsules for Colon Cancer Therapy In Vivo
PEGylated versus non-PEGylated magnetic nanoparticles as camptothecin delivery system
Promising PEGylated cationic dendrimers for delivery of miRNAs as a possible therapy against HIV-1 infection
PEGylated recombinant human hyaluronidase (PEGPH20) pre-treatment improves intra-tumour distribution and efficacy of paclitaxel in preclinical models
Elevated alpha1-acid glycoprotein in gastric cancer patients inhibits the anticancer effects of paclitaxel, effects restored by co-administration of erythromycin
Observation of antitumor mechanism of GE11-modified paclitaxel and curcumin liposomes based on cellular morphology changes
Safety evaluation of PEGylated MNPs and p-PEGylated MNPs in SD rats
Efficient Delivery of Gold Nanoparticles and miRNA-33a Via Cationic PEGylated Niosomal Formulation to MCF-7 Breast Cancer Cells
Co-delivery of paclitaxel and curcumin to foliate positive cancer cells using Pluronic-coated iron oxide nanoparticles